Apotea AB (publ) (STU:V30) Piotroski F-Score: N/A (As of Aug. 25, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STU:V30 Apotea AB (publ) STU:V30
26 GF Score
Price €6.79
! 1 Warning Sign
View Full Analysis

What is Apotea AB (publ) Piotroski F-Score?

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Apotea AB (publ) has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.

The historical rank and industry rank for Apotea AB (publ)'s Piotroski F-Score or its related term are showing as below:

During the past 5 years, the highest Piotroski F-Score of Apotea AB (publ) was 5. The lowest was 4. And the median was 5.

Apotea AB (publ)  (STU:V30) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Apotea AB (publ) Piotroski F-Score Related Terms


Apotea AB (publ) Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Apotea AB (publ)'s Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Apotea AB (publ) Piotroski F-Score Chart

Apotea AB (publ) Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Piotroski F-Score
N/A N/A N/A N/A 4.00

Apotea AB (publ) Quarterly Data
Dec21 Dec22 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only N/A 5.00 4.00 N/A N/A

Apotea AB (publ) Piotroski F-Score Competitor Comparison

For the Pharmaceutical Retailers subindustry, Apotea AB (publ)'s Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Apotea AB (publ) Piotroski F-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Apotea AB (publ)'s Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Apotea AB (publ)'s Piotroski F-Score falls into.


STU:V30
26GF Score
Apotea AB (publ) STU:V30
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun26) TTM:Last Year (Jun25) TTM:
Net Income was 6.327 + 1.415 + 7.353 + 7.425 = €22.5 Mil.
Cash Flow from Operations was 9.945 + -5.945 + 10.444 + 7.006 = €21.5 Mil.
Revenue was 160.833 + 170.396 + 179.848 + 184.802 = €695.9 Mil.
Gross Profit was 43.733 + 42.188 + 50.959 + 50.882 = €187.8 Mil.
Average Total Assets from the begining of this year (Jun25)
to the end of this year (Jun26) was
(179.353 + 205.703 + 181.992 + 206.177 + 203.037) / 5 = €195.2524 Mil.
Total Assets at the begining of this year (Jun25) was €179.4 Mil.
Long-Term Debt & Capital Lease Obligation was €19.8 Mil.
Total Current Assets was €133.4 Mil.
Total Current Liabilities was €95.3 Mil.
Net Income was 4.95 + 4.295 + 6.536 + 6.547 = €22.3 Mil.

Revenue was 143.161 + 150.653 + 160.073 + 165.823 = €619.7 Mil.
Gross Profit was 39.109 + 40.678 + 44.265 + 46.382 = €170.4 Mil.
Average Total Assets from the begining of last year (Jun24)
to the end of last year (Jun25) was
(0 + 132.441 + 141.507 + 175.482 + 179.353) / 5 = €157.19575 Mil.
Total Assets at the begining of last year (Jun24) was €0.0 Mil.
Long-Term Debt & Capital Lease Obligation was €24.1 Mil.
Total Current Assets was €100.1 Mil.
Total Current Liabilities was €84.6 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Apotea AB (publ)'s current Net Income (TTM) was 22.5. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Apotea AB (publ)'s current Cash Flow from Operations (TTM) was 21.5. ==> Positive ==> Score 1.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Jun25)
=22.52/179.353
=0.12556244

ROA (Last Year)=Net Income/Total Assets (Jun24)
=22.328/0
=

Apotea AB (publ)'s return on assets of this year was 0.12556244. Apotea AB (publ)'s return on assets of last year was . ==> This year is higher. ==> Score 1.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Apotea AB (publ)'s current Net Income (TTM) was 22.5. Apotea AB (publ)'s current Cash Flow from Operations (TTM) was 21.5. ==> 21.5 <= 22.5 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Jun26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun25 to Jun26
=19.849/195.2524
=0.10165816

Gearing (Last Year: Jun25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Jun24 to Jun25
=24.063/157.19575
=0.15307666

Apotea AB (publ)'s gearing of this year was 0.10165816. Apotea AB (publ)'s gearing of last year was 0.15307666. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Jun26)=Total Current Assets/Total Current Liabilities
=133.381/95.334
=1.39909161

Current Ratio (Last Year: Jun25)=Total Current Assets/Total Current Liabilities
=100.137/84.61
=1.18351259

Apotea AB (publ)'s current ratio of this year was 1.39909161. Apotea AB (publ)'s current ratio of last year was 1.18351259. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Apotea AB (publ)'s number of shares in issue this year was 104.095. Apotea AB (publ)'s number of shares in issue last year was 104.118. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=187.762/695.879
=0.2698199

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=170.434/619.71
=0.27502219

Apotea AB (publ)'s gross margin of this year was 0.2698199. Apotea AB (publ)'s gross margin of last year was 0.27502219. ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Jun25)
=695.879/179.353
=3.87994068

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Jun24)
=619.71/0
=

Apotea AB (publ)'s asset turnover of this year was 3.87994068. Apotea AB (publ)'s asset turnover of last year was . ==> This year's asset turnover is higher. ==> Score 1.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+1+1+0+1+1+1+0+1
=7

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Apotea AB (publ) has an F-score of 7. It is a good or high score, which usually indicates a very healthy situation.


Apotea AB (publ) Business Description

Other Exchanges APOTEA:Sweden
Address Sveavagen 168, Stockholm, SWE, 11346
Apotea AB (publ) is engaged in the online pharmacy with fast deliveries, good prices and a large selection. Its vision is to be tomorrow's pharmacy by constantly facilitating and simplifying for the customer.
26GF Score

Get the complete analysis for STU:V30

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.79
Price